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Antibodies of various specificities 
may be found in patients receiving 
multiple blood transfusions. Investi-
gations in the past decade have es-
tablished that some of these patients 
may develop antibodies specifically 
directed against leukocyte antigens 
and not against those of the red cells 
(Bridges, Boyd, and Nelson , 1962; 
Dausset, 1954; Felbo and Jensen, 
1962; Killman, 1958; Payne, 1947 ; 
van Loghem et al, 1958; van Rood , 
Leeuwen, and Eernisse, 1959; van 
Leeuwen, 1963). The transfusion of 
patients whose sera contain these 
antibodies, known as leukoaggluti-
nins, frequent ly results in febrile 
transfusion reactions. In the past, 
most febri le transfusion reactions 
were attributed to the presence of 
pyrogens in the blood-collecting ap-
paratus. However, with the use of 
disposable equipment, this source of 
reactions has been virtually elimi-
nated, and most authors agree that 
leukocyte-leukoagglutinin incom-
patibility is a major cause of such 
febri le reactions today (Bridges, 
Boyd, and Nelson, 1962; Britting-
ham, and Chaplin, 1957; Dausset, 
1954; Hossaini ; Killman, 1958; 
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Payne, 1957; van Loghem et al, 
1958; Wilson, Rheins, Naegeli , and 
George, J 959). This study was un-
dertaken to determine in vivo and 
in vitro the specificity of leuko-
agglutinins, and to establish the na-
ture of the pyrogenic reaction . 
Materials and Methods 
Normal sera were obtained from 
donors in the blood bank of the 
Ohio State University Hospital. All 
pathologic sera were obtained from 
patients on the hematology service 
of the department of medicine. 
Leukocyte Suspensions 
Blood was collected from normal 
donors in the blood bank in 15 ml 
amounts in si liconized tubes con-
taining 0.3 ml of 5% disodium ver-
senate (EDTA). After thorough 
mixing of blood and anticoagulant, 
2 ml of 6% dextran were added, 
and the contents of the tube were 
mixed again by inversion. The 
blood was divided equally and 
pipetted into three 22 x 1.5 cm test 
tubes. After 90 minutes of sedimen-
tation, the supernatant plasma, rich 
in leukocytes and platelets, was 
transferred to a 15 ml graduated 
centrifuge tube. The tube was spun 
in a centrifuge at 800 rpm for 15 
minutes. The supernatant fluid was 
removed and, by the same centrifu-
gation technique, the cells in the 
sediment were washed twice with 
saline-serum-anticoagulant (SSA) 
solution. The latter solution was 
prepared by mixing 2 ml of inacti-
vated normal blood group AB 
serum with 0.5 ml of 5% EDTA , 
and then diluting it to 200 ml with 
physiological saline. After the sec-
ond washing, the supernatant was 
removed as completely as possible, 
and the button of cells was homoge-
neously suspended in a fresh 0.5 ml 
aliquot of SSA solution. A white cell 
count was made, and additional 
SSA was added to produce a cel l 
density of 8 to 10,000 per mm". 
Red Cells 
The red cell portion remammg 
after sedimentation was washed in 
saline and was used for the absorp-
tion of erythrocyte isoagglutinins. 
All erythrocyte isoagglutinins were 
removed from test sera by absorp-
tion with washed red cells of the 
leukocyte donor before Jeukoagglu-
tination tests were performed. 
Leukoagglutination Test 
The leukoagglutination tests were 
performed by placing 0.2 ml of a 
1: 8 dilution of the absorbed sera in 
physiological saline in 10 x 75 ml 
tubes, followed by one drop of 
bromelin solution (Dade Reagents, 
Inc. , Miami, Florida) or 0.1 ml of 
the SSA suspended leukocytes. The 
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tubes were shaken, left to stand for 
15 minutes at room temperature, 
and then were spun for 30 seconds 
in a serofuge (Clay-Adams). After 
tapping the tubes gently to disperse 
the cells in the sediment, the solu-
tions were examined for agglutina-
tion by holding the tubes in the 
direct beam of a light source over a 
concave magnifying mirror. 
A known positive control and a 
negative control were included in 
each series of tests. Each serum 
was tested against two cell suspen-
sions prepared from randomly se-
lected donors. 
Induction of Febrile Transfusion 
Reaction 
The following sera were used: 
1. Serum from a Group A, Rho 
(D) positive blood patient with 
aplastic anemia, whose serum had 
shown strong Jeukoagglutinating ac-
tivity. 
2. Serum from an apparently 
normal individual (negative control) 
of the same blood group and Rho 
(D) as that of the patient. 
Five ml of both the control and 
the leukoagglutinin-positive sera 
were diluted to 30 ml using injec-
table physiological saline followed 
by Seitz-filtration. 
Basal white cell and differential, 
red cell, reticulocyte, and platelet 
counts were obtained by finger stick; 
temperature, pulse rate, and blood 
pressure were recorded on a male 
volunteer (AAH). Two hours after 
obtaining the basal data, a slow 
intravenous transfusion of 250 ml 
of physiological saline was begun. 
Twenty-five minutes later the con-
trol Seitz-filtered serum was in-
jected into the saline bottle and in-
fusion continued. At half-hourly 
intervals for six hours, counts were 
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taken, and temperature, pulse, and 
pressure were recorded. 
Under similar environmental, 
temporal and nutritional conditions, 
the same volunteer was injected one 
week later with an equal amount of 
the identically processed positive 
serum, and similar observations 
were recorded as above. 
Results 
In all, 395 sera obtained from 
375 normal individuals and patients 
with various pathological conditions 
were tested for leukoagglutinins. 
When a patient gave a negative test 
and subsequently became positive, 
the reactions were recorded as two 
specimens; this accounts for the 
difference in numbers. There were 
20 such cases. Many of the path-
ological groups had received multi-
ple transfusions. Results of the sera 
tested for Jeukoagglutinins and the 
number of transfusions received by 
each patient prior to the first testing 
of the serum are shown in Table 1. 
Table 2 lists the diagnoses of pa-
tients whose sera were tested for 
leukoagglutinins before they re-
ceived any blood transfusions. None 
of the seven Jeukoagglutinin-posi-
tive sera was from a woman who 
had ever been pregnant. 
Cytologic studies of agglutinated 
cells revealed participation of both 
the granulocytes and mononuclear 
cells in the clumps. Clumping re-
sulted in complete loss of the ame-
boid movement of cells in the posi-
tive tubes, whereas cells in the 
negative sera remained mobile, 
though sluggish. 
Transfused patients were classi-
fied by clinical diagnosis. Those 
showing transfusion reactions, Jeu-
koagglutinins, or both, are pre-
sented in Table 3. 
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TABLE 1 
Distribution of 395 Sera Tested for L.A.* 
Number L.A. Number of blood units tested No L.A. demon-
strated 
From patients never transfused prior to 247 240t 7 
testing 
From patients receiving less than 8 units 63 48 15 
From patients receiving more than 8 but 59 42 17 
less than 20 units 
From patients receiving more than 20 16 9 7 
but less than 50 units 
From patients receiving more than 50 10 3 7 
units 
Total 395 342 53 
* L.A.: Leukoagglutinins 
t Some of these patients were subsequently transfused and re-tested. 
TABLE 3 
Correlation between Disease, Transfusion Reaction and L.A. Production 
Number Showing 
Disease Group Reac- Reac- L.A. Both ti on tion and 
only negative Total only L.A. 
--- - -----
Acute leukemias 3 7 6 22 38 
Chronic leukemias 4 10 4 19 37 
Lymphomas 4 4 1 15 24 
Hemolytic anemias 4 2 0 6 12 
Refractory anemias 4 4 0 7 15 
Thrombocytopenic purpuras 0 2 0 0 2 
Coagulation defects 1 0 0 4 5 
Non-hematologic diseases* . 2 5 1 5 13 
Insufficient data 2 
Total 22 34 12 78 148 
* Six untransfused patients showed leukoagglutinins (L.A.) . (See Table 1) 
TABLE 2 
Diseases Found in Patients Show-
ing Negative and Positive Leuko-
agglutinis Prior to Receiving any 
Transfusion 
Num-Num-
b ber Disease er . 
tested posi-
tive 
Rheumatoid arthri- 9 4 
tis 
Chronic pyelone- 4 
phritis 
Acute monoblastic 18 
leukemia 
Healthy 76 1 
Miscellaneous* 133 0 
Total 240 7 
* Diseases included: 
1. Other acute leukemias 
2. Chronic leukemias 
3. Lymphomas 
4. Hemolytic anemias 
5. Refractory anemias 
6. Lupus erythematosus dis-
seminatus 
7. Coagulation defects 
8. Various forms of non-
hematologic diseases 
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Figure 1 shows white cell, red 
cell, platelet, and reticulocyte 
counts, temperature, and symptoms 
experienced during the infusion of 
both the control and positive sera. 
No change occurred in these pa-
rameters following the infusion of 
the control serum. On the contrary, 
the following alterations occurred 
after the infusion of the positive 
serum. One hour after the start of 
the infusion of serum, there was a 
marked leukopenia, lasting for 90 
minutes, followed by a gradual re-
turn to the basal level, and a sub-
sequent leukocytosis over the next 
three hours. Only slight changes in 
the reticulocyte and red cell counts 
occurred, but a significant thrombo-
cytopenia was observed. Platelet 
levels remained at the basal value 
for two hours, but 30 minutes later 
the count showed a precipitous 
drop. The thrombocytopenia per-
sisted for two hours, and then the 
count returned to normal levels. No 
further counts were made. 
Fifteen minutes before the com-
pletion of the infusion (40 minutes 
after starting the serum infusion), 
the subject developed a frontal 
headache, which increased in in-
tensity over a period of an hour. 
Within 15 minutes after the onset 
of the headache, a shaking chill, a 
mild tachypnea (28 breaths per 
minute), and a 2-3° rise in tem-
perature (which reached its peak 
within three hours) developed. 
Table 4 shows the basal red cell, 
reticulocyte, platelet, white cell, and 
differential counts and the values 
obtained over the six hour study 
period following the injection of the 
positive serum. Since detailed list-
ing of the hourly values following 
the injection of the control serum 
did not contribute additional infor-
mation, only the recorded range of 
values were included in this table. 
The values obtained with regard to 
the red cell, reticulocyte, platelet, 
and total white cell counts have 
been mentioned already in Figure 1. 
Differential counts obtained after 
the infusion of the control serum 
varied slightly from basal values. 
However, there were marked abso-
lute neutrophenia, eosinopenia, lym-
phopenia and monocytopenia. The 
neutrophenia continued for over 
three hours and was followed by 
a neutrophilic leukocytosis. Val-
ues for the remaining white cell 
elements remained below normal 
levels over the six-hour period. 
However, the monocytes showed 
signs of reappearance five hours 
after infusion. 
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TABLE 4 
Changes Induced in a Human Volunteer by Injection of Leukoagglutinin 
Positive Control Sera 
I. 
Control 
Serum 
Cells Range of 
values 
over 6 
hours 0 
- -
RBC 's in millions 5.2- 5.3 5.8 
--
Reticulocytes 3 1.2-2.0 1.6 
Platelets in 1000 's 190-208 214 
WBC Total 4150-5000 5000 
- -
Polys. Total 3050-3071 3300 
3 61-74 66 
- -
Eos. Total 0-250 0 
% 0-5 0 
--
Baso. Total 0-0 0 
% 0-0 0 
- -
Lympho. Total 747-900 1300 
3 18- 27 26 
Mono. Total 125-150 400 
3 2- 3 8 
Discussion 
This study confirms the work of 
other investigators (Bridges, Boyd, 
and Nelson, 1962; Dausset, 1954; 
Felbo and Jensen, 1962; Killman, 
1958; van Rood, Leeuwen, and 
Eernisse, 1959; van Rood and von 
Leeuwen, 1963; Wilson, Rheins, 
Naegeli, and George, 1959) that the 
mechanism of the leukoagglutina-
Test Serum 
Time in hours after injection 
1 2 3 4 5 6 
--
- -
----
- - --
5.5 5.5 6.1 5.1 5.1 5.2 
- - - - -
----
--
--
0.2 0 .8 0.4 1.4 0.4 0.6 
--
----
-----
- -
184 204 36 74 194 -
------- -
--
--
1950 2300 4500 6500 8650 12950 
----- - --
----
1287 1656 4095 6175 8391 12600 
66 72 91 95 97 95 
--
- - ----
----
0 0 0 0 0 0 
0 0 0 0 0 0 
----- -
----
--
0 0 0 0 0 0 
0 0 0 0 0 0 
- -
--
--~~ 
--
--- -
546 552 360 325 173 88 
28 24 8 5 2 3 
----- - - - --
--
117 92 45 0 86 259 
6 4 1 0 1 2 
tion phenomenon is immunologic 
and is specific for leukocytes. There 
is a significantly higher frequency 
of occurrence of leukoagglutinins in 
patients receiving multiple transfu-
sions as compared to patients who 
were not transfused. Table 1 shows 
that only seven out of 247 sera from 
the latter group gave a positive test. 
In contrast, 46 out of 148 sera from 
transfused patients were positive. 
Twelve of the leukoagglutinin-
positive patients had been tested 
before any transfusion. All their 
sera were negative then, but became 
positive after one or more blood 
transfusions. Yet other patients, 
who had been tested at different 
stages of transfusion therapy, were 
found to become leukoagglutinin-
positive as the number of transfu-
sions was increased. Table 1 shows 
the direct relationship between the 
number of leukoagglutinin-positive 
patients and the number of units of 
blood they had received. Among the 
46 leukocyte agglutinating sera 
from transfused patients, only three 
were known to possess a concomi-
tant red cell antibody. Therefore, 
the increase in the number of leuko-
agglutinin-positive patients with in-
creasing transfusions may have been 
caused by further stimulation by the 
antigen or antigens of transfused 
leukocytes. 
Absence of reaction following the 
injection of the control serum indi-
cates that all pyrogenic agents had 
been eliminated from the serum. 
Variations in differentials, in blood 
counts and temperatures, in pulses 
and pressures during the negative 
control experiment were within the 
range of physiological variations 
and experimental error. 
Excluding the unlikely possibility 
of sensitization by the negative con-
trol serum, it may be assumed that 
the reaction to the positive serum 
was due to the specific effect of the 
injected leukoagglutinins on circu-
lating leukocytes. The possibility of 
a pyrogenic reaction must be con-
sidered, however, as marked leuko-
penia is not characteristic of this 
type of transfusion reaction. 
The marked leukopenia in the 
absence of a change in the red cell 
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count indicates that the reaction was 
not caused by erythrocyte anti-
bodies. The simultaneous onset of 
neutropenia, eosinopenia, lympho-
penia and monocytopenia is addi-
tional evidence suggesting that the 
antibody is directed against granular 
and mononuclear leukocytes. This 
reinforces the findings by micro-
scopic studies that both cell types 
participate in the clumps of cells 
seen in positive leukoagglutinin 
tests. The thrombocytopenia was 
shown to be associated with the 
presence of platelet antibodies in 
the injected serum. 
The injection of a serum known 
to contain leukoagglutinins into a 
normal individual resulted in the 
development of a febrile reaction 
and a mild leukopenia. In an earlier 
report, one of us (AAH) explained 
this on the basis of passive transfer 
of leukoagglutinins. 
Using the continuous-flow elec-
trophoresis cell, Wilson, Rheins, 
and Naegeli (1959) fractionated 
seven negative sera and ten sera 
from six leukoagglutinin-positive 
patients. Results showed a rise in 
activity of the y-globulin fraction 
only in the positive sera. Persistence 
of leukoagglutinins in positive sera 
after absorption indicates that the 
red cells lacked the corresponding 
antigens. 
There was an absence of a 
marked reduction in the severity of 
febrile transfusion reactions when 
packed red cells with a leukocyte 
count of less than 1000 per mm3 
were given to three leukoagglutinin-
positive patients who had experi-
enced multiple febrile transfusion 
reactions. The mild reactions after 
receiving the processed blood might 
have been due to the almost in-
evitable contamination of packed, 
washed, red cell preparations by a 
few unremoved leukocytes. 
Summary 
Results of testing sera from nor-
mal individuals and pathological pa-
tients, using a bromelin technique 
for the detection of leukoaggluti-
nins, are reported. These results, 
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supported further by an in vivo 
experiment, suggested that the phe-
nomenon of leukoagglutination is 
immunologic in nature and that leu-
koagglutinins may be the cause of 
some febrile transfusion reactions. 
These are specifically directed 
against leukocytes, and do not in-
volve the red cell series. Further-
more, the antigen (or antigens) is 
probably present in both the granu-
locytes and the mononuclear leuko-
cytes. Anti-platelet antibodies could 
be presumed to be the cause of 
thrombocytopenia. 
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